 |
Callio Therapeutics
Last updated: March 04, 2025
CEO - Piers Ingram
USA | Funding: $187M (+)
Website: https://calliotx.com/
Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).
Website: https://calliotx.com/
Callio Therapeutics develops next-generation, multi-payload antibody-drug conjugates (ADCs).
